Drugs / mononuclear cord blood cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05693181 | Dec 2022 → Dec 2024 | spinal cord injury | Sklifosovsky Institute of Emergency Care | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mononuclear cord blood cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05693181 ↗ |
| Modality | Cell therapy | “Cell Therapy” NCT05693181 ↗ |
| Route | Intravenous | “systemic (i.v.) administration” NCT05693181 ↗ |